ABBV logo

AbbVie (ABBV) Company Overview

Profile

Full Name:

AbbVie Inc.

Sector:

Healthcare

Country:

United States

IPO:

January 2, 2013

Indexes:

Description:

AbbVie Inc. is a global research-based biopharmaceutical company established in 2013 after separating from Abbott Laboratories. The headquarters are located in North Chicago, Illinois. AbbVie develops and promotes advanced treatments for some of the most complex and serious diseases in the world: chronic autoimmune diseases; oncology; virology, including hepatitis C virus and human immunodeficiency virus (HIV); Parkinson's disease; metabolic diseases (thyroid diseases and complications from cystic fibrosis) and others. All of the company's products meet industry standards and have patent protection.

Key Details

Price

$214.49

Annual Revenue

$56.33 B(+3.71% YoY)

Annual EPS

$2.39(-12.13% YoY)

Beta

0.12

Events Calendar

Earnings

Next earnings date:

Apr 25, 2025

Recent quarterly earnings:

Jan 31, 2025

Recent annual earnings:

Jan 31, 2025
Dividend

Next ex-dividend date:

Apr 15, 2025

Recent ex-dividend date:

Jan 15, 2025
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 5, 25 Wells Fargo
Overweight
Mar 4, 25 B of A Securities
Neutral
Feb 3, 25 Wells Fargo
Overweight
Feb 3, 25 UBS
Neutral
Feb 3, 25 Truist Securities
Buy
Feb 3, 25 Raymond James
Outperform
Feb 3, 25 Morgan Stanley
Overweight
Feb 3, 25 Guggenheim
Buy
Feb 3, 25 Citigroup
Buy
Feb 3, 25 BMO Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for AbbVie?
  • Does AbbVie pay dividends?
  • What sector is AbbVie in?
  • What industry is AbbVie in?
  • What country is AbbVie based in?
  • When did AbbVie go public?
  • Is AbbVie in the S&P 500?
  • Is AbbVie in the NASDAQ 100?
  • Is AbbVie in the Dow Jones?
  • When was AbbVie's last earnings report?
  • When does AbbVie report earnings?
  • Should I buy AbbVie stock now?

What is the ticker symbol for AbbVie?

The ticker symbol for AbbVie is NYSE:ABBV

Does AbbVie pay dividends?

Yes, AbbVie pays dividends. The last payment was $1.64, with an ex-dividend date on January 15, 2025

What sector is AbbVie in?

AbbVie is in the Healthcare sector

What industry is AbbVie in?

AbbVie is in the Drug Manufacturers - General industry

What country is AbbVie based in?

AbbVie is headquartered in United States

When did AbbVie go public?

AbbVie's initial public offering (IPO) was on January 2, 2013

Is AbbVie in the S&P 500?

Yes, AbbVie is included in the S&P 500 index

Is AbbVie in the NASDAQ 100?

No, AbbVie is not included in the NASDAQ 100 index

Is AbbVie in the Dow Jones?

No, AbbVie is not included in the Dow Jones index

When was AbbVie's last earnings report?

AbbVie's most recent earnings report was on Jan 31, 2025

When does AbbVie report earnings?

The next expected earnings date for AbbVie is Apr 25, 2025

Should I buy AbbVie stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions